Harvest Technologies Corporation Files Amended Patent Infringement Complaint against ThermoGenesis Corporation and Celling Technologies LLC
PLYMOUTH, Mass., Feb. 20, 2013 /PRNewswire/ -- Harvest Technologies Corporation (Harvest) announced that it filed an amended patent infringement complaint on February 15, 2013 in the US District Court of Delaware against ThermoGenesis Corporation (ThermoGenesis) and Celling Technologies LLC. The complaint was amended to include Celling Technologies and alleges that the ThermoGenesis' Res-Q™ 60 BMC system, also sold by Celling Technologies as the ART 21® BMC System, infringes two patents for which Harvest Technology owns the rights. These patents relate to Harvest's proprietary floating shelf technology that has been shown in studies to provide superior cellular concentration. The complaint also requests an injunction against further sales of the product in the U.S.
"Harvest Technologies has invested many years and millions of dollars in development of its cellular therapy products," said Gael Tisack, Vice President of Intellectual Property for Terumo Americas Holding. "We will continue to take all steps necessary to ensure that we protect our intellectual property and enforce our patent rights."
Harvest Technologies is the leading cellular therapy global manufacturer that has developed point-of-care products to process and concentrate multiple biologics. These include high-density platelet rich plasma (APC+®), bone marrow aspirate concentrate (BMAC®) and adipose tissue. The company is headquartered in Plymouth, Massachusetts. It is one of several subsidiaries of Terumo Corporation of Japan that is focused in cellular therapies and biologics. For more information, visit www.harvesttech.com or call 508-732-7500.
Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures, and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use.
Harvest is a registered trademark of Harvest Technologies Corporation. Terumo® is a registered trademark of Terumo Corporation. Res-Q is a trademark of ThermoGenesis Corporation. Celling Technologies® is a registered trademark of Celling Technologies LLC. ART 21 is a trademark of Celling Technologies®
SOURCE Harvest Technologies Corporation